CLEAN : Ebola vaccine trials begin in Switzerland 2

The video discusses a trial involving 400 volunteers, with 120 selected for participation. Of these, 50 will go to West Africa, and 70 will stay in Switzerland. The trial is deemed safe for both volunteers and those handling biological samples. The speaker expresses personal motivation to help expedite vaccine development, despite not being able to conduct research directly.

How many volunteers have expressed interest to participate in the trial?

What is the distribution of the 400 volunteers in terms of their locations?

What assurances are given regarding the safety of the volunteers?

What is the purpose of the volunteers participating in the trial?

What feelings does the speaker express about participating in the trial?